Why the study?
Do CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms affect clopidogrel response variability and the risk of stent thrombosis in Chinese patients with coronary heart disease?
Population
162 Chinese patients with coronary heart disease treated with aspirin and clopidogrel, along with a…
Comparison
Presence of CES1A2 AC, CYP2C19 *2/*3, PON1… vs Absence of these polymorphisms
Design
Cohort
Authors
Loading...
CYP2C19 LOF alleles may aid stent thrombosis risk stratification in Chinese patients on clopidogrel; leaves open CES1A2 role and requires prospective validation.
Do CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms affect clopidogrel response variability and the risk of stent thrombosis in Chinese patients with coronary heart disease?
Both CES1A2 -816C and CYP2C19 loss-of-function alleles are associated with attenuated platelet reactivity to clopidogrel, and CYP2C19 LOF predicts stent thrombosis in Chinese patients with coronary heart disease.
Xie et al. (2014) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: